Potential therapeutic and pharmacological strategies for SARS-CoV2.

ABSTRACT:

Background

At the end of 2019, the new Coronavirus disease 2019 (COVID-19) strain causing severe acute respiratory syndrome swept the world. From November 2019 till February 2021, this virus infected nearly 104 million, with more than two million deaths and about 25 million active cases. This has prompted scientists to discover effective drugs to combat this pandemic.

Area covered

Drug repurposing is the magic bullet for treating severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). Therefore, several drugs have been investigated in silico, in vitro, as well as through human trials such as anti-SARS-CoV2 agents, or to prevent the complications resulting from the virus. In this review, the mechanisms of action of different therapeutic strategies are summarized. Accordi

SUBMITTER: Ghareeb DA 

PROVIDER: S-EPMC7933375 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature